All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0762 | Anti-PARK7 (13k4) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 13k4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0763 | Anti-PARK7 (1B11) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1B11 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0764 | Anti-PARK7 (3E8) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 3E8 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0765 | Anti-PARK7 (16) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 16 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0766 | Anti-PARK7 (48) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 48 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0767 | Anti-PARK7 (3843) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 3843 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1662 | Anti-PARK7 (13k4) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 13k4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1663 | Anti-PARK7 (1B11) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1B11 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1664 | Anti-PARK7 (3E8) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 3E8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1665 | Anti-PARK7 (16) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 16 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1666 | Anti-PARK7 (48) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 48 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1667 | Anti-PARK7 (3843) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 3843 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION